BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31625124)

  • 1. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.
    Kito F; Oyama R; Noguchi R; Hattori E; Sakumoto M; Endo M; Kobayashi E; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jan; 33(1):283-290. PubMed ID: 31625124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1).
    Harnisch K; Steiner S; Pliego-Mendieta A; Chen Y; Planas-Paz L; Pauli C
    Hum Cell; 2024 Jan; 37(1):356-363. PubMed ID: 37951844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors.
    Oyama R; Kito F; Takahashi M; Hattori E; Noguchi R; Takai Y; Sakumoto M; Qiao Z; Toki S; Sugawara M; Tanzawa Y; Kobayashi E; Nakatani F; Iwata S; Yoshida A; Kawai A; Kondo T
    Cancer Cell Int; 2020; 20():58. PubMed ID: 32099531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
    Ono T; Noguchi R; Yoshimatsu Y; Tsuchiya R; Sin Y; Nakagawa R; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
    Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
    Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
    Ono T; Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Akiyama T; Kojima N; Toda Y; Sato C; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2023 Sep; 36(5):1804-1812. PubMed ID: 37328637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Jan; 34(1):279-288. PubMed ID: 33001379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2020 Oct; 33(4):1321-1328. PubMed ID: 32815117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
    Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.
    Berner K; Bjerkehagen B; Bruland ØS; Berner A
    Anticancer Res; 2015 Apr; 35(4):2129-40. PubMed ID: 25862869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
    Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Sugiyama M; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jul; 33(3):886-893. PubMed ID: 32300959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
    Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sugaya J; Kobayashi E; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Jan; 34(1):246-253. PubMed ID: 32870449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.